info@biomedres.us
+1 (502) 904-2126
One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA
Site Map
ISSN: 2574 -1241
ISSN: 2574 -1241
Received: May 23, 2018; Published: May 29, 2018
DOI: 10.26717/BJSTR.2018.04.001119
Low efficiency of classic antitumor therapy initiates search for new ways of early diagnostics, prophylaxis and treatment of tumors. Specialists sometimes pay attention to extraordinary strategies based, for example, on the use of stem cells (SC) as specific biological agents aimed at destruction of malignant gliomas [1-3]. These technologies are the result of stem cells fundamental ability to migrate to brain tumors penetrating through blood-brain barrier [1].
Abbrevations: MiRs: MicroRNAs, SCs: Stem Cells, TNF-α: Tumor Necrosis Factor
Introduction| Stem cells and malignant glioma cells| Contradictions in the technique of stem cells implantation in brain tumors| Conclusion| Acknowledgement| References|
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China
Lecturer at the School of Energy and Chemical Engineering, Xiamen University Malaysia, Malaysia
Full Text
PDF
